Fulgent Genetics Inc (FLGT)
Healthcare
Diagnostics & Research
16.60 $
-18.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Fulgent Genetics Inc (FLGT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -102 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.4 | -1.0 | 4.4 | 1.3 | -0.7 | 5.5 | 141 | 539 | 254 | 27 | 21 | -102 | |
| 0.2 | 0.6 | 1.2 | 1.7 | 2.2 | 2.5 | 3.0 | 11 | 33 | 26 | 25 | 24 | |
| – | 8.2 | 4.7 | 2.1 | 2.3 | 3.2 | 8.2 | 16 | 33 | 43 | 44 | 40 | |
| 0.0 | 8.5 | 10 | 2.8 | 3.7 | 4.2 | 8.7 | 23 | 75 | – | – | – | |
| -0.3 | -1.7 | -1.9 | -0.7 | -1.2 | -0.9 | -91 | -2.7 | 2.0 | 2.8 | -7.2 | -118 | |
| 0.7 | 2.1 | 3.8 | 5.4 | 2.8 | 1.2 | 37 | 24 | 19 | 22 | 40 | 23 | |
| -0.8 | -2.2 | -43 | -2.0 | 1.0 | -29 | -326 | -547 | -261 | 39 | -58 | 111 | |
| 4.6 | 4.6 | 4.6 | 0.0 | – | – | 15 | 4.2 | – | – | – | – | |
| 37 | 37 | -6.6 | 0.0 | 0.0 | 0.0 | -0.1 | -4.2 | -76 | -28 | -3.1 | -14 | |
| – | – | – | 15 | 15 | 15 | 15 | 0.0 | -1.1 | -20 | -1.8 | -0.9 | |
| 4.0 | 3.5 | 46 | -0.8 | 0.0 | 29 | 261 | 85 | -77 | -48 | -4.8 | -15 | |
| -1.2 | 0.3 | 7.4 | -1.4 | 0.2 | 5.2 | 75 | 77 | -85 | 18 | -42 | -5.0 | |
| -5.1 | -3.1 | 0.6 | -4.0 | -3.5 | 4.3 | 104 | 515 | 235 | 4.8 | -19 | -124 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.